The Venous Center

Filter Your Results

 

News

 

Medtronic Commences IDE Study of In.Pact AV Access DCB in Patients With End-Stage Renal Disease

May 24, 2017 -- Medtronic announced that the first patient has been enrolled in a study of the company's In.Pact AV Access drug-coated balloon (DCB) under a US F…

OPTALYSE PE Study Evaluates Shorter, Lower-Dose Thrombolysis With Ekos Therapy

May 22, 2017 -- BTG International announced that the results of the OPTALYSE PE trial showed that pulmonary embolism (PE) can be treated effectively with the company'…

Office-Based Labs: A Clinical Overview of Therapies and Devices

With Donald S. Cross, MD, FACC; Alberto Gonzalez, MD, FACS; and Kenneth J. Wright, MD, FACS

May 2017—The second in a four-part series discussing office-based labs (OBLs) and ambulatory surgery centers (ASCs) from the perspectives of three physicians.

FDA Approves Feasibility Study of LimFlow's PDVA System to Treat End-Stage CLI Patients

April 26, 2017 -- LimFlow SA announced that the US Food and Drug Administration has approved the company's investigational device exemption for a feasibilit…

Three-Year VeClose Data and 1-Year WAVES Data Presented for Medtronic's VenaSeal Closure System

April 25, 2017 -- Medtronic announced 3-year outcomes from the VeClose United States pivotal clinical trial and 1-year data from the WAVES study, which were presented by Kathl…

ATTRACT 2-Year Data and Commentary

April 2017—Two-year ATTRACT data show that anticoagulation alone is best for most deep vein thrombosis; pharmacomechanical catheter-directed thrombolysis benefits seen in certain iliofemoral patients.

Study Evaluates Impact of UK NICE Guideline for Leg Ulcers on Treatment Referrals

April 19, 2017 -- Huw O.B. Davies, MD, et al conducted an evaluation of the impact of the United Kingdom's National Institute for Health and Care Excellence (NICE) Clinica…

American College of Phlebology Provides Update on the ACP PRO Venous Registry

April 18, 2017 -- The American College of Phlebology (ACP) announced that the ACP PRO Venous Registry's database now contains more than 19,000 unique patients and 77,000 p…

 

advertisement

2017 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.